Enquire now

AKBA Ultra

Tested: Clinically tested for management of Osteoarthritis symptoms. Tested for sub-acute and acute toxicity in humans.

Constituents: Complex of 5 major Boswellic Acids:

  • 30% AKBA (3-O-acetyl-11-keto-β-boswellic acid) active content, the most effective form of Boswellic acid
  • 40% total Boswellic Acid (by HPLC)
  • 75-85% total Boswellic Acids (By titration)

Benefits:  Human clinical study shows a marked reduction in pain and stiffness, and the inflammatory markets.

  • Decrease in VAS score, LF score, WOMAC pain, WOMAC stiffness & WOMAC function scores
  • Improvement in Joint mobility & comfort
  • Drop down in the levels of Inflammatory markers